Identification of self-management indicators for chronic hepatitis B patients with antiviral therapy

来源 :第二十三次全国中西医结合肝病学术会议 | 被引量 : 0次 | 上传用户:todo158
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: The objective of this study was to establish consensus about which indicators best characterize self-management for chronic hepatitis B (CHB) patients with antiviral therapy.Methods: A 2-round Delphi survey via email correspondence was conducted,with a group of 33 Chinese experts in the field of CHB.The survey consisted of 58 items under four major domains: treatment management,daily life management,psychosocial management and information management,identified from a literature review and the findings of interviews with CHB patients.Participants rated and scored the importance of indicators on a five-point Likert scale ranging from very important to very unimportant.Items with 70% or above of participants rating a statement as important or very important after Round 2 would be included.The average authority coefficients and Kendalls Coefficient of Concordance were also analyzed.Results: The response rates for the first and second rounds were 90.9% (n=30) and 86.7% (n=26),respectively.Following the two rounds,an expert consensus was reached on 47 of the original 58 indicators.All included indicators had a median of 4 or above,and 44 indicators (93.6%) had an IQR of 1 or below.The strength of agreement between expert raters for the four domains was moderate and the average authority coefficients ranged from 0.84 to 0.96 in Round 2.Conclusion: 47 self-management indicators for CHB patients with antiviral therapy have been identified.These indicators constitute the first step in contributing to the development and validation of a self-management instrument for CHB patients with antiviral therapy.
其他文献
目的:探讨白藜芦醇通过诱导自噬抑制HSC活化的机制.方法:采用不同浓度的白藜芦醇干预小鼠HSC株JS-1,自噬抑制剂3-MA、CQ及siAtg7干扰抑制自噬,zVAD-FMK抑制凋亡.MTT检测细胞活性,Western blot和RT-PCR检测HSC活化指标(α-SMA和Col.Ⅰ)、自噬指标(LC3B、p62、Atg7)、凋亡指标(Cleaved-Caspase3)的表达,RFP-GFP-LC
目的:分析重型肝炎的预后因素.方法:回顾性分析2000年7月至2013年12月在我院住院的389例重型肝炎患者,分为治疗有效组和治疗无效组,借助SPSS软件,分析各种因素对其预后的影响.结果:logistic回归分析两组之间肝性脑病(sig显著性0.000)、HBV-DNA载量(sig显著性0.001)、凝血酶原活动度(sig显著性0.000)、总胆红素(sig显著性0.003)有显著性差异.结论
目的:通过高脂饮食建立非酒精性脂肪性肝炎大鼠模型,观察益肝解毒方对其血清生化和肝组织UCP-2的影响.方法:将40只SD大鼠随机分成正常组、模型组、中药组、西药组,模型组、中药组、西药组给予高脂饲料喂养12周以复制非酒精性脂肪性肝炎模型,中药组以中药灌胃,西药组以多烯磷脂酰胆碱灌胃,疗程8周.20周后处死大鼠,收集标本.测定各组大鼠体质量、肝重、肝体比、血清甘油三酯(TG)、总胆固醇(TC)、高密
目的:探讨化痰祛湿活血方对非酒精性脂肪性肝炎(NASH)大鼠脂联素及其受体与肝组织病理学改变的影响.方法:通过高脂饲料联合四环素腹腔注射建立大鼠NASH模型.造模第2周分别给予各高脂模型组动物化痰祛湿活血方高、中、低剂量和多烯磷脂酰胆碱(易善复)胶囊干预.实验结束时,测定各组血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、甘油三酯(TG)、总胆固醇(TC)水平,肝组织切片油红0染色.结果:与易善复
目的:探讨红背叶根4种不同提取物:水提物(wE),石油醚提取物(PE),乙酸乙酯提取物(EE),正丁醇提取物(BE)防治Con-A诱导小鼠急性肝损伤的进一步机制.方法:保护实验:70只NIH雄性小鼠随机分成正常对照组、Con-A模型组、阳性对照药甘利欣(GLX)及红背叶根WE组、PE组、EE组、BE组等7个组,每组10只.红背叶根4种提取物分别按药效学原则,以7.8g生药·kg-1灌胃给药,阳性对
目的:探讨红背叶根4种不同提取物:原药水提物,石油醚提取物,乙酸乙酯提取物,正丁醇提取物对Con-A诱导的小鼠急性肝损伤的保护与治疗作用,筛选相应的有效部位.方法:保护实验:150只NIH雄性小鼠随机均分成正常组、Con A模型组、对照药甘利欣组及红背叶根原药水提物、石油醚、乙酸乙酯、正丁醇提取物低、中、高剂量组,给药组以生药3.9g·kg-1,7.8g·kg-1,15.6g·kg-1为低、中、高
会议
会议
目的:比较退黄汤(THT)和熊去氧胆酸(UDCA)对α-异硫氰酸萘酯(ANIT)诱导大鼠肝损过程保护作用,探讨其药理差异及可能作用机制.方法:选取Sprague-Dawley (SD)大鼠66只,设立空白组6只,对剩余60只在0h时间点均以ANIT100 mg/kg予以灌胃造成急性肝损伤,在肝损后24 h取6只处死留取标本(肝损24 h组),然后分为生理盐水组(18只,9 ml/kg体重的生理盐水
目的:探讨异硫氰酸苄酯(benzyl isothiocyanate,BITC)对人肝癌HepG2细胞增殖的抑制作用及其机制.方法:BITC作用HepG2细胞后,应用MTS法检测BITC对肿瘤细胞增殖的影响,流式细胞术检测BITC对肿瘤细胞凋亡、细胞周期、活性氧(ROS)表达的作用,酶标仪检测caspase-3/8活性的变化,Western blotting法检测Survivin、cyclin B1
目的:探讨扶正化瘀方对于慢加急性肝衰竭形成及严重程度的防治作用.方法: 66只雄性Wistar大鼠随机分成正常对照组(6只)、急性肝衰竭组(8只)慢性肝炎模型组(6只)、慢性肝炎干预组(6只),慢加急性肝衰竭模型组(20只)、慢加急性肝衰竭干预组(20只),采用50%四氯化碳植物油溶液腹腔注射建立肝纤维化模型,干预组予扶正化瘀方灌胃干预治疗,第9周用D-氨基半乳糖急性攻击正常大鼠、慢性肝炎模型大鼠